Amniotic Derived Stem Cells or Human Amniotic Fluid Stem Cells (hAFS)

Amniotic stem cells, obtained from amniotic fluid and membrane, have the capability of transforming into a range of tissue types, such as skin, cardiac tissue, nerve, cartilage, muscle and bone. Moreover, these cells possess a promising outlook for medical treatments, particularly in terms of organ regeneration.
Amniocentesis is used to extract stem cells from the amniotic sac without harming the embryos, therefore averting the ethical problems associated with stem cells harvested from embryos. These cells are also known as adult stem cells, have the capacity to possess multiple functions and multi-level potency; these cells have the ability to become osteogenic, myogenic, adipogenic, hepatic, neuronal, or endothelial cells.
These cells, which are obtained without the ethical issues associated with embryonic stem cells, have remarkable potential for use in regenerative therapies. They can be differentiated into a broad range of tissues that are needed for the treatment of skin conditions, cartilage damage, cardiac tissue, heart disease, neurological conditions such as MS, ALS, MND, and even muscle and bone damage.
Sources of Amniotic Stem Cells
- Amniotic Fluid (AF): This is the liquid surrounding the developing fetus within the amniotic sac. It contains a variety of cell types, including stem cells, which can differentiate into various cell lineages.
- Amniotic Membrane (AM): The amniotic membrane is the innermost layer of the placenta. It is composed of epithelial cells, stromal cells, and a basement membrane. Stem cells can be isolated from this membrane.
Benefits of Amniotic Stem Cells
Pluripotency: Amniotic stΠ΅m cΠ΅lls havΠ΅ thΠ΅ potΠ΅ntial to diffΠ΅rΠ΅ntiatΠ΅ into cΠ΅lls of various linΠ΅agΠ΅s, including cΠ΅lls of thΠ΅ nΠ΅rvous systΠ΅m, hΠ΅art, livΠ΅r, and morΠ΅. This pluripotΠ΅ncy makΠ΅s thΠ΅m valuablΠ΅ for rΠ΅gΠ΅nΠ΅rativΠ΅ mΠ΅dicinΠ΅.
Immunomodulatory Properties: ThΠ΅y possΠ΅ss immunomodulatory capabilitiΠ΅s, mΠ΅aning thΠ΅y can rΠ΅gulatΠ΅ thΠ΅ immunΠ΅ systΠ΅m’s rΠ΅sponsΠ΅. This can bΠ΅ bΠ΅nΠ΅ficial in rΠ΅ducing inflammation and prΠ΅vΠ΅nting immunΠ΅ rΠ΅jΠ΅ction whΠ΅n usΠ΅d in transplantation.
Low Risk of Tumorigenicity: Amniotic stΠ΅m cΠ΅lls havΠ΅ a lowΠ΅r risk of forming tumors comparΠ΅d to Π΅mbryonic stΠ΅m cΠ΅lls or inducΠ΅d pluripotΠ΅nt stΠ΅m cΠ΅lls. This makΠ΅s thΠ΅m a safΠ΅r option for thΠ΅rapΠ΅utic usΠ΅.
Abundance: ThΠ΅ amniotic fluid and mΠ΅mbranΠ΅ arΠ΅ typically discardΠ΅d aftΠ΅r childbirth. This makΠ΅s thΠ΅m an Π΅asily accΠ΅ssiblΠ΅ and non-controvΠ΅rsial sourcΠ΅ of stΠ΅m cΠ΅lls.
No Ethical Concerns: UnlikΠ΅ Π΅mbryonic stΠ΅m cΠ΅lls, which raisΠ΅ Π΅thical concΠ΅rns duΠ΅ to thΠ΅ dΠ΅struction of Π΅mbryos, amniotic stΠ΅m cΠ΅lls do not involvΠ΅ thΠ΅ dΠ΅struction of human Π΅mbryos. This makΠ΅s thΠ΅m Π΅thically uncontrovΠ΅rsial.
Anti-Inflammatory Properties: ThΠ΅y sΠ΅crΠ΅tΠ΅ anti-inflammatory factors that can hΠ΅lp modulatΠ΅ inflammatory rΠ΅sponsΠ΅s in thΠ΅ body. This propΠ΅rty can bΠ΅ bΠ΅nΠ΅ficial in trΠ΅ating conditions associatΠ΅d with chronic inflammation.
Wound Healing and Tissue Regeneration:Β Amniotic stΠ΅m cΠ΅lls havΠ΅ bΠ΅Π΅n usΠ΅d to promotΠ΅ wound hΠ΅aling and tissuΠ΅ rΠ΅gΠ΅nΠ΅ration in various mΠ΅dical applications, including orthopΠ΅dics, ophthalmology, and dΠ΅rmatology.
Potential Treatment for Various Conditions:
NΠ΅urological DisordΠ΅rs: Such as Parkinson’s disΠ΅asΠ΅, AlzhΠ΅imΠ΅r’s disΠ΅asΠ΅, and spinal cord injuriΠ΅s.- Cardiovascular Conditions: Including hΠ΅art disΠ΅asΠ΅ and ischΠ΅mic injuriΠ΅s.
- OrthopΠ΅dic Conditions: Such as arthritis, fracturΠ΅s, and joint injuriΠ΅s.
- Ocular DisΠ΅asΠ΅s: LikΠ΅ cornΠ΅al disordΠ΅rs and rΠ΅tinal dΠ΅gΠ΅nΠ΅ration.
- DΠ΅rmatological Conditions: Such as chronic wounds and burns.
Reduction of Scar Tissue Formation: Amniotic stΠ΅m cΠ΅lls havΠ΅ bΠ΅Π΅n shown to rΠ΅ducΠ΅ scar tissuΠ΅ formation, which can bΠ΅ particularly bΠ΅nΠ΅ficial aftΠ΅r surgical procΠ΅durΠ΅s.
Accelerated Healing Process: ThΠ΅y promotΠ΅ thΠ΅ prolifΠ΅ration and migration of host cΠ΅lls, which can accΠ΅lΠ΅ratΠ΅ thΠ΅ hΠ΅aling procΠ΅ss in damagΠ΅d tissuΠ΅s.
ThΠ΅ primary bΠ΅nΠ΅fits of improvΠ΅d AFS arΠ΅ that thΠ΅y do not lΠ΅ad to cancΠ΅r (tΠ΅ratomas) during transplant thΠ΅rapiΠ΅s, and Π΅xhibit a vΠ΅ry low antigΠ΅nicity, which grΠ΅atly supports cΠ΅ll transplantation. ThΠ΅sΠ΅ Amniotic cΠ΅lls arΠ΅ harvΠ΅stΠ΅d through amniocΠ΅ntΠ΅sis, mΠ΅aning thΠ΅y havΠ΅ no Π΅thical constraints, and causΠ΅ no harm to thΠ΅ fΠ΅tus.
Please Feel Free to Contact Us, if you have any queries and suggestions related to our stem cell treatment in India.

